SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-19-000013
Filing Date
2019-07-16
Accepted
2019-07-16 08:50:11
Documents
6
Period of Report
2019-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k_071619x2.htm 6-K 371820
2 GRAPHIC a1gc.jpg GRAPHIC 449392
3 GRAPHIC a2gc.jpg GRAPHIC 292308
4 GRAPHIC a3gc.jpg GRAPHIC 225412
5 GRAPHIC a4gc.jpg GRAPHIC 192857
6 GRAPHIC en201907.jpg GRAPHIC 242477
  Complete submission text file 0001395064-19-000013.txt   2303813
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 19956244
SIC: 2834 Pharmaceutical Preparations